|
Dr. Levetan is a noted endocrinologist with expertise spanning diverse areas of diabetes. She has been internationally recognized for the translation of science and technology into improved health care options for patients with diabetes. Dr. Levetan’s current research focus is identifying peptides in the human proteome, which differentiate progenitor pancreatic cells into new islets. In 2007, Dr. Levetan received the American College of Endocrinology’s Highest Distinction in Clinical Endocrinology Award that is presented annually to the endocrinologist recognized as having achieved distinction in the field of clinical endocrinology; and has a sustained record of devotion to teaching the art and science of endocrinology. She served as an associate editor of the journals, Clinical Diabetes and Diabetes Forecast. Upon completion of two terms as associate editor of the American Diabetes Association’s journal, Clinical Diabetes, Dr. Irl Hirsch, the Editor in Chief, wrote in an editorial, Dr. Resa Levetan is perhaps the most creative physician I have ever met. Her ideas for developing interesting articles, translating new information to others, and getting physicians, patients, and their families involved with diabetes to obtain better outcomes are truly inspired. Dr. Levetan’s has been on the forefront of diabetes research and has been published in many medical journals including the American Journal of Medicine. She has testified before the U.S. Congress on the economic and health benefits of empowering patients to take a more active role in their own care. She has led research teams in the areas of methods to prevent and reverse diabetes, and was an investigator on the NIH’s Diabetes Prevention Program and Women’s Health Initiative. She is actively involved in reviewing diabetes scientific articles for the Journal of the American Medical Association, Diabetes Care, Endocrine Practice and many other physician and patient publications. She was the co-chair of the American College of Endocrinology’s Diabetes Outpatient and Inpatient Consensus Conferences. Dr. Levetan served on the steering committee of Medicare and National Committee for Quality Assurance’s (NCQA’s) and Diabetes Quality Improvement Project (DQIP). She served on the Board of Directors of the American Association of Clinical Endocrinologists and was on the Board of Trustees of the American College of Endocrinology. Dr. Levetan is a graduate of Emory University School of Medicine. She was Professor of Medicine and Chief of Endocrinology, Diabetes and Metabolism at Medical College of Pennsylvania Hospital and Drexel University College of Medicine and is now Chief Scientific Officer of CureDM Inc., which she co-founded. She is a clinical professor at the Lankenau Institute for Medical Research at Lankenau Hospital/Jefferson Health System in Wynnewood, Pa. | 